Català, Martí
Li, Xintong
Prats, Clara
Prieto-Alhambra, Daniel
Funding for this research was provided by:
La Caixa Foundation (LCF/PR/GN17/50300003)
National Institute for Health Research (SRF-2018-11-ST2-004)
Ministerio de Ciencia e Innovación, Gobierno de España (PGC2018-095456-B-I00)
Article History
Received: 21 April 2021
Accepted: 6 September 2021
First Online: 22 September 2021
Competing interests
: Dr. Prats reports Grants from Ministerio de Ciencia e Innovación, Gobierno de España (PGC2018-095456-B-I00), during the conduct of the study; other from European Commission, DG-CONNECT (CNECT/LUX/2020/LVP/0085, LC-01591965) and Janssen, outside the submitted work. Dr. Prieto-Alhambra reports Grants and other from AMGEN, Grants, non-financial support and other from UCB Biopharma, Grants from Les Laboratoires Servier, outside the submitted work; and HTA Funding Committee membership. Janssen, on behalf of IMI-funded EHDEN and EMIF consortiums, and Synapse Management Partners have supported training programmes organised by DPA's department and open for external participants. Dr. CATALÀ reports Grants from Ministerio de Ciencia e Innovación, Gobierno de España (PGC2018-095456-B-I00), Grants from La Caixa Foundation (ID 100010434), under agreement LCF/PR/GN17/50300003, during the conduct of the study; other from European Commission, DG-CONNECT (CNECT/LUX/2020/LVP/0085, LC-01591965), outside the submitted work. Ms. Li has nothing to disclose.